Search

everythinglearnresearchcommunity

for

Search:↓

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

A young woman with severe symptoms of CPAN improved with intensive treatment but needed a leg amputation.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Prednisone treatment helped a woman with Cronkhite-Canada syndrome recover from hair loss and digestive issues.

Some drugs may help treat both COVID-19 and radiation injury.

Tacrolimus can cause hair loss in kidney transplant patients.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

Clofazimine effectively treated ashy dermatosis in a patient.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Vitamin D protects skin cells from damage caused by captopril.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Itraconazole may cause low platelet and white blood cell counts.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.